二甲双胍与2型糖尿病中的癌症 - Suppr

Suppr

超能文献

Metformin and cancer in type 2 diabetes.

作者信息

Park Hyeong Kyu

机构信息

Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.

出版信息

Diabetes Metab J. 2013 Apr;37(2):113-6. doi: 10.4093/dmj.2013.37.2.113.

DOI:10.4093/dmj.2013.37.2.113

PMID:23641351

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3638221/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ab/3638221/2d588562d2c8/dmj-37-113-g001.jpg

相似文献

Metformin and cancer in type 2 diabetes.

Diabetes Metab J. 2013 Apr;37(2):113-6. doi: 10.4093/dmj.2013.37.2.113.

Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.

Medicine (Baltimore). 2017 Jul;96(29):e7605. doi: 10.1097/MD.0000000000007605.

Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.

Obstet Gynecol. 2012 Jan;119(1):61-7. doi: 10.1097/AOG.0b013e3182393ab3.

Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes.

Endokrynol Pol. 2017;68(6):652-658. doi: 10.5603/EP.a2017.0054. Epub 2017 Oct 12.

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes.

Diabetes Metab J. 2013 Apr;37(2):125-31. doi: 10.4093/dmj.2013.37.2.125. Epub 2013 Apr 16.

Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.

Diabetes Care. 2011 Oct;34(10):2323-8. doi: 10.2337/dc11-0512.

Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study.

Pharmacotherapy. 2014 Jan;34(1):36-45. doi: 10.1002/phar.1334. Epub 2013 Jul 17.

Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.

J Clin Endocrinol Metab. 2012 Jul;97(7):2347-53. doi: 10.1210/jc.2012-1267. Epub 2012 Apr 20.

Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.

Am J Med Sci. 2019 Sep;358(3):200-203. doi: 10.1016/j.amjms.2019.06.002. Epub 2019 Jul 4.

Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.

Oncotarget. 2017 Feb 28;8(9):16017-16026. doi: 10.18632/oncotarget.13762.

引用本文的文献

Diabetes, metformin and cancer risk in myotonic dystrophy type I.

Int J Cancer. 2020 Aug 1;147(3):785-792. doi: 10.1002/ijc.32801. Epub 2019 Dec 19.

Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.

Mol Clin Oncol. 2018 Mar;8(3):504-512. doi: 10.3892/mco.2018.1554. Epub 2018 Jan 11.

Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.

BMC Cancer. 2018 Jan 10;18(1):65. doi: 10.1186/s12885-017-3934-9.

The association between metabolic health, obesity phenotype and the risk of breast cancer.

Int J Cancer. 2017 Jun 15;140(12):2657-2666. doi: 10.1002/ijc.30684. Epub 2017 Mar 28.

Insulin signaling regulates a functional interaction between adenomatous polyposis coli and cytoplasmic dynein.

Mol Biol Cell. 2017 Mar 1;28(5):587-599. doi: 10.1091/mbc.E16-07-0555. Epub 2017 Jan 5.

Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells.

Diabetes Metab J. 2015 Dec;39(6):518-27. doi: 10.4093/dmj.2015.39.6.518.

Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.

Autophagy. 2015;11(1):46-59. doi: 10.4161/15548627.2014.984271.

Nutrition and healthy ageing: calorie restriction or polyphenol-rich "MediterrAsian" diet?

Oxid Med Cell Longev. 2013;2013:707421. doi: 10.1155/2013/707421. Epub 2013 Aug 28.

本文引用的文献

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes.

Diabetes Metab J. 2013 Apr;37(2):125-31. doi: 10.4093/dmj.2013.37.2.125. Epub 2013 Apr 16.

Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

Metabolism. 2013 Jul;62(7):922-34. doi: 10.1016/j.metabol.2013.01.014. Epub 2013 Feb 16.

Association of metformin use with cancer incidence and mortality: a meta-analysis.

Cancer Epidemiol. 2013 Jun;37(3):207-18. doi: 10.1016/j.canep.2012.12.009. Epub 2013 Jan 24.

Diabetes and cancer I: risk, survival, and implications for screening.

Cancer Causes Control. 2012 Jun;23(6):967-81. doi: 10.1007/s10552-012-9972-3. Epub 2012 May 3.

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.

PLoS One. 2012;7(3):e33411. doi: 10.1371/journal.pone.0033411. Epub 2012 Mar 20.

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.

Diabetes Care. 2012 Feb;35(2):299-304. doi: 10.2337/dc11-1313. Epub 2012 Jan 20.

Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.

Ann N Y Acad Sci. 2011 Dec;1243:54-68. doi: 10.1111/j.1749-6632.2011.06285.x.

Cellular and molecular mechanisms of metformin: an overview.

Clin Sci (Lond). 2012 Mar;122(6):253-70. doi: 10.1042/CS20110386.

The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.

Breast Cancer Res. 2011 Oct 21;13(5):R99. doi: 10.1186/bcr3040.

Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.

Diabetes Care. 2011 Oct;34(10):2323-8. doi: 10.2337/dc11-0512.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验